Source: Health Products Regulatory Authority (ZA) Revision Year: 2022 Publisher: Litha Pharma (Pty) Ltd, 106 16th Road, Midrand, 1686
Emergency contraception within 72 hours of unprotected sexual intercourse or failure of a contraceptive method.
The tablet should be taken, no later than 72 hours after unprotected intercourse.
If the patient vomits within three to four hours of taking the tablet, another tablet should be taken immediately.
ESCAPELLE can be used at any time during the menstrual cycle unless menstrual bleeding is overdue.
After using emergency contraception it is recommended to use a local barrier method (e.g. condom) until the next menstrual period starts. The use of ESCAPELLE does not contraindicate the continuation of regular hormonal contraception.
Children: ESCAPELLE is not recommended in children.
Very limited data are available in women under 16 years of age.
For oral administration.
Serious undesirable effects have not been reported following acute ingestion of large doses of oral contraceptives. Overdose may cause nausea, and withdrawal bleeding may occur. There are no specific antidotes and treatment should be symptomatic and supportive.
5 years.
Store at or below 25°C. Protect from light.
Store in the original container until required for use.
The folded carton of ESCAPELLE contains one aluminium/PVC blister of one tablet.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
